PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12947397::ACT038881

P1

Evidence text

Paper-level observation

The cumulative survival rate of the AMP group was higher than that of the VP group (P < 0.05) and lower than that of the CG group (P < 0.05).
textConfidence: medium

Assay observation

Activity
Antimicrobial
Subtype
Antibacterial
Measure
survival_rate
Comparator
<
Raw observation
The cumulative survival rate of the AMP group was higher than that of the VP group (P < 0.05) and lower than that of the CG group (P < 0.05).
Normalized measurement
<0.05
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Litopenaeus vannamei
Assay method
Not reported by source
Sequence
FIKRIARLLRKIF
Standardization
ready simple

Source publication

Effect of the antimicrobial peptide BmKn2-7 in inhibiting Vibrio parahaemolyticus and its role in improving microbiota, immunity and Vibrio resistance in Litopenaeus vannamei.

BMC Veterinary Research · 2026

DOI 10.1186/s12917-025-05264-z PMC12947397
Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-003501PEPDIA-INT-064110

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.